| CXHL2101618 | 盐酸米托蒽醌脂质体注射液 | mitoxantrone hydrochloride | Injection | Chemical Drugs(2.4) | New Drug Application | 2021-10-29 | | Cspc Heibei Zhongrun Pharmaceutiacl Co Ltd | | | view |
| CXHL2101544 | 盐酸米托蒽醌脂质体注射液 | mitoxantrone hydrochloride | Injection | Chemical Drugs(2.4) | New Drug Application | 2021-10-14 | | Cspc Heibei Zhongrun Pharmaceutiacl Co Ltd | | | view |
| CXHL2101172 | 盐酸米托蒽醌脂质体注射液 | mitoxantrone hydrochloride | Injection | Chemical Drugs(2.4) | New Drug Application | 2021-06-04 | | Cspc Heibei Zhongrun Pharmaceutiacl Co Ltd | | | view |
| JXHL1400106 | ABT-333 Film Coated Tablet | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
| JXHL1400104 | ABT-333 Film Coated Tablet | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-04-02 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-07-15 | view |
| JXHL1300201 | Atrasentan HCl Tablets | atrasentan | Tablet | Chemical Drugs | Import Drug Application | 2013-06-03 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2014-09-10 | view |
| JXHL1300200 | Atrasentan HCl Tablets | atrasentan | Tablet | Chemical Drugs | Import Drug Application | 2013-06-18 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2014-09-10 | view |
| JXHL2100096 | Atrasentan片 | atrasentan | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 艾昆纬医药科技（上海）有限公司 | Aikunwei Medical Technology (Shanghai) Co Ltd | In Review | 2021-03-19 | view |
| JXHB2300170 | Atrasentan片 | atrasentan | Tablet | Chemical Drugs(1) | Supplementary Application | 2023-11-08 | | | | | view |
| JXHB2400133 | Atrasentan片 | atrasentan | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-08-01 | | | | | view |
| JXHB2200156 | Atrasentan片 | atrasentan | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-10-10 | | | | | view |
| JXHL1000130 | BMS-790052片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2010-05-13 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2011-08-31 | view |
| JXHL1000132 | BMS-790052片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2010-05-05 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2011-08-05 | view |
| JXHL1000131 | BMS-790052片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2010-05-05 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2011-08-05 | view |
| JXHL1100431 | BMS-790052片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2011-12-07 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2013-01-25 | view |
| CXHL1800097 | D20140305-1盐酸盐 | D20140305-1 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-06-28 | 江苏恩华药业股份有限公司 | Jiangsu Nhwa Pharmaceutical Co Ltd | In Review | 2018-06-26 | view |
| CXHL1800098 | D20140305-1盐酸盐片 | D20140305-1 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-06-28 | 江苏恩华药业股份有限公司 | Jiangsu Nhwa Pharmaceutical Co Ltd | Certificate Issued | 2018-09-19 | view |
| JXHL1400061 | Daclatasvir Dihydrochloride片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-03-12 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2015-06-01 | view |
| JXHL1200351 | Daclatasvir Dihydrochloride片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2012-11-08 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2013-06-03 | view |
| JXHL1400385 | Daclatasvir Dihydrochloride片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2014-12-04 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2016-09-29 | view |
